.Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J01M_QuinoloneAntibacterials.J01MA23_Delafloxacin.Delafloxacin_1 .Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J01M_QuinoloneAntibacterials.J01MA23_Delafloxacin.Delafloxacin_1| name: | Delafloxacin_1 | |
| ATC code: | J01MA23_1 | |
| route: | oral | |
| compartments: | 2 | |
| dosage: | 450 | mg |
| volume of distribution: | 35.0 | L |
| clearance: | 9.3 | L/h |
| other parameters in model implementation | ||
Delafloxacin is a fluoroquinolone antibiotic approved for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) and community-acquired bacterial pneumonia (CABP) in adults. It is active against a broad range of Gram-positive and Gram-negative bacteria, including MRSA.
Population pharmacokinetic model for healthy adult subjects and patients, both male and female, aged 18–85 years; values representative for a single 450 mg oral dose, fasted.